Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPOSIT: Vemurafenib plus Cobimetinib in Advanced Melanoma
NCT02414750Phase 2Terminated
- Start
- Dec 2014
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cobimetinib in melanoma. Started Dec 2014; status: terminated.
02
Drugs
cobimetinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02414750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414750.